An experimental drug helped significantly more overweight patients with diabetes shed pounds, compared with placebo, a new study finds. The results were presented at The Endocrine Society's 94th Annual Meeting in Houston.



"This new medication is promising because of the amount of weight loss it produces, the resultant improvement in important risk factors for diabetes, and, particularly in the lower dose studied, in its tolerability," said study lead author Donna H. Ryan, M.D., professor emeritus at Pennington Biomedical Research Center (LSU System) in Baton Rouge, LA.

 

Continued at MedicalNewsToday>>

Follow  

How much of your time would you estimate you spend growing your business?